These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8635396)

  • 1. The role of neoadjuvant chemotherapy in NSCLC.
    Tonato M
    Chest; 1996 May; 109(5 Suppl):93S-95S. PubMed ID: 8635396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future].
    Mellas N; Elmesbahi O; Masbah O; Errihani H
    Bull Cancer; 2010 Feb; 97(2):211-23. PubMed ID: 20051349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.
    Betticher DC
    Lung Cancer; 2005 Dec; 50 Suppl 2():S9-16. PubMed ID: 16557669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small cell lung cancer.
    Carretta A; Chiesa G; Zannini P; Villa E; Verusio C; Fumagalli F; Melloni G; Grossi A
    Eur J Cardiothorac Surg; 1994; 8(9):457-61. PubMed ID: 7811477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy in non-small-cell lung cancer].
    Larsen SS; Pedersen JJ; Krasnik M; Jensen TS
    Ugeskr Laeger; 1999 Nov; 161(45):6169-73. PubMed ID: 10603752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
    Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R
    Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
    Splinter TA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.
    Crinò L; Cappuzzo F
    Lung Cancer; 2001 Dec; 34 Suppl 3():S45-7. PubMed ID: 11740993
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Lee HW; Noh OK; Oh YT; Choi JH; Chun M; Kim HI; Heo J; Ahn MS; Park SY; Park RW; Yoon D
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):621-7. PubMed ID: 26867891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W
    Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chemotherapy in stages I to III non-small cell lung cancer.
    Strauss GM
    Chest; 1999 Dec; 116(6 Suppl):509S-516S. PubMed ID: 10619521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer.
    Pujol JL; Le Chevalier T; Ray P; Gautier V; Rouanet P; Arriagada R; Grunenwald D; Michel FB
    Lung Cancer; 1995 Apr; 12 Suppl 1():S107-18. PubMed ID: 7551918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current situation of neoadjuvant chemotherapy in non-small-cell bronchogenic carcinoma].
    Soler Cataluña JJ; Perpiña Tordera M
    Arch Bronconeumol; 1998 Apr; 34(4):174-6. PubMed ID: 9611650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S; Zaliene A; Atkocius V
    Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.